Rapid Micro Biosystems to Announce Fourth Quarter and Full

Rapid Micro Biosystems to Announce Fourth Quarter and Full

LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology......

Micron Technology to Report Fiscal Second Quarter Results

Micron Technology to Report Fiscal Second Quarter Results

BOISE, Idaho, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal second quarter......

STRATA Skin Sciences Announces TheraClear®X Product

STRATA Skin Sciences Announces TheraClear®X Product

HORSHAM, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,......

STEALTHGAS INC. Announces the Date for the Release of the

STEALTHGAS INC. Announces the Date for the Release of the

ATHENS, Greece, Feb. 16, 2023 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum......

Workhorse Group Sets Fourth Quarter and Full Year 2022

Workhorse Group Sets Fourth Quarter and Full Year 2022

CINCINNATI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused......

Cerberus Sentinel Announces Termination of Public Offering

Cerberus Sentinel Announces Termination of Public Offering

Scottsdale, Ariz., Feb. 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Cerberus Cyber Sentinel Corporation (“Cerberus Sentinel” or the “Company”)......

Kura Oncology to Report Fourth Quarter and Full Year 2022

Kura Oncology to Report Fourth Quarter and Full Year 2022

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the......

Arbutus to Report Fourth Quarter and Year End 2022

Arbutus to Report Fourth Quarter and Year End 2022

WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging......

Intellia Therapeutics to Hold Conference Call to Discuss

Intellia Therapeutics to Hold Conference Call to Discuss

CAMBRIDGE, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on......

Decibel Therapeutics to Present at the Upcoming SVB

Decibel Therapeutics to Present at the Upcoming SVB

BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and......

  • 1
  • ...
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • ...
  • 44
  • menu
    menu